NCT01682083
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01682083
Title Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). (COMBI-AD)
Acronym COMBI-AD
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | NZL | NOR | NLD | ITA | ISR | GRC | GBR | FRA | ESP | DNK | DEU | CZE | CHE | CAN | BRA | BEL | AUT | AUS | ARG

Facility Status City State Zip Country Details
Novartis Investigative Site Birmingham Alabama 35243 United States Details
Novartis Investigative Site Tucson Arizona 85724 United States Details
Novartis Investigative Site San Francisco California 94115 United States Details
Novartis Investigative Site San Francisco California 94143 United States Details
Novartis Investigative Site Aurora Colorado 80045 United States Details
Novartis Investigative Site Lake Worth Florida 33461 United States Details
Novartis Investigative Site Orlando Florida 32806 United States Details
Novartis Investigative Site Tampa Florida 33612 United States Details
Novartis Investigative Site Atlanta Georgia 30322 United States Details
Novartis Investigative Site Atlanta Georgia 30341 United States Details
Novartis Investigative Site Lutherville-Timonium Maryland 21093 United States Details
Novartis Investigative Site Boston Massachusetts 02114 United States Details
Novartis Investigative Site Boston Massachusetts 02115 United States Details
Novartis Investigative Site Ann Arbor Michigan 48019 United States Details
Novartis Investigative Site Winston-Salem North Carolina 27157 United States Details
Novartis Investigative Site Columbus Ohio 43210 United States Details
Novartis Investigative Site Portland Oregon 97123 United States Details
Novartis Investigative Site Pittsburgh Pennsylvania 15232 United States Details
Novartis Investigative Site Nashville Tennessee 37203 United States Details
Novartis Investigative Site Dallas Texas 75390 United States Details
Novartis Investigative Site Capital Federal Buenos Aires C1426ANZ Argentina Details
Novartis Investigative Site Buenos Aires C1125ABD Argentina Details
Novartis Investigative Site Gateshead New South Wales 2290 Australia Details
Novartis Investigative Site North Sydney New South Wales 2060 Australia Details
Novartis Investigative Site Tweed Heads New South Wales 2485 Australia Details
Novartis Investigative Site Westmead New South Wales 2145 Australia Details
Novartis Investigative Site Greenslopes Queensland 4120 Australia Details
Novartis Investigative Site Woolloongabba Queensland 4102 Australia Details
Novartis Investigative Site Adelaide South Australia 5000 Australia Details
Novartis Investigative Site Box Hill Victoria 3128 Australia Details
Novartis Investigative Site Heidelberg Victoria 3084 Australia Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Graz 8036 Austria Details
Novartis Investigative Site Linz A-4010 Austria Details
Novartis Investigative Site Salzburg A-5020 Austria Details
Novartis Investigative Site Vienna 1090 Austria Details
Novartis Investigative Site Wels A-4600 Austria Details
Novartis Investigative Site Brussels 1200 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Liège 4000 Belgium Details
Novartis Investigative Site Wilrijk 2610 Belgium Details
Novartis Investigative Site Curitiba Paraná 81520-060 Brazil Details
Novartis Investigative Site Ijuí Rio Grande do Sul 98700 Brazil Details
Novartis Investigative Site Edmonton Alberta T6G 1Z2 Canada Details
Novartis Investigative Site Hamilton Ontario L8V 5C2 Canada Details
Novartis Investigative Site Oshawa Ontario L1G 2B9 Canada Details
Novartis Investigative Site Ottawa Ontario K1H 8L6 Canada Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Québec Quebec G1J 1Z4 Canada Details
Novartis Investigative Site Brno 656 53 Czechia Details
Novartis Investigative Site Prague 100 34 Czechia Details
Novartis Investigative Site Prague 128 08 Czechia Details
Novartis Investigative Site Zlín 76275 Czechia Details
Novartis Investigative Site Arhus C 8000 Denmark Details
Novartis Investigative Site Herlev 2730 Denmark Details
Novartis Investigative Site Odense 5000 C Denmark Details
Novartis Investigative Site Bordeaux 33075 France Details
Novartis Investigative Site Boulogne-Billancourt 92100 France Details
Novartis Investigative Site Brest 29609 France Details
Novartis Investigative Site Dijon 21079 France Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Marseille 13385 France Details
Novartis Investigative Site Montpellier 34295 France Details
Novartis Investigative Site Nice 06202 France Details
Novartis Investigative Site Paris 75014 France Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Pierre-Bénite 69495 France Details
Novartis Investigative Site Reims 51092 France Details
Novartis Investigative Site Rennes 35042 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Tours 37044 France Details
Novartis Investigative Site Villejuif 94805 France Details
Novartis Investigative Site Freiburg im Breisgau Baden-Wurttemberg 79104 Germany Details
Novartis Investigative Site Heilbronn Baden-Wurttemberg 74078 Germany Details
Novartis Investigative Site Mannheim Baden-Wurttemberg 68167 Germany Details
Novartis Investigative Site Tübingen Baden-Wurttemberg 72076 Germany Details
Novartis Investigative Site Ulm Baden-Wurttemberg 89081 Germany Details
Novartis Investigative Site Munich Bavaria 80337 Germany Details
Novartis Investigative Site Nuremberg Bavaria 90419 Germany Details
Novartis Investigative Site Regensburg Bavaria 93053 Germany Details
Novartis Investigative Site Würzburg Bavaria 97080 Germany Details
Novartis Investigative Site Darmstadt Hesse 64297 Germany Details
Novartis Investigative Site Marburg Hesse 35033 Germany Details
Novartis Investigative Site Wiesbaden Hesse 65199 Germany Details
Novartis Investigative Site Hanover Lower Saxony 30625 Germany Details
Novartis Investigative Site Schwerin Mecklenburg-Vorpommern 19049 Germany Details
Novartis Investigative Site Bochum North Rhine-Westphalia 44791 Germany Details
Novartis Investigative Site Cologne North Rhine-Westphalia 50937 Germany Details
Novartis Investigative Site Essen North Rhine-Westphalia 45147 Germany Details
Novartis Investigative Site Mainz Rhineland-Palatinate 55131 Germany Details
Novartis Investigative Site Magdeburg Saxony-Anhalt 39120 Germany Details
Novartis Investigative Site Kiel Schleswig-Holstein 24105 Germany Details
Novartis Investigative Site Lübeck Schleswig-Holstein 23538 Germany Details
Novartis Investigative Site Erfurt Thuringia 99089 Germany Details
Novartis Investigative Site Gera Thuringia 07548 Germany Details
Novartis Investigative Site Berlin 10249 Germany Details
Novartis Investigative Site Athens 11527 Greece Details
Novartis Investigative Site Thessaloniki 54622 Greece Details
Novartis Investigative Site Thessaloniki 56429 Greece Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Rome Lazio 00167 Italy Details
Novartis Investigative Site Genoa Liguria 16132 Italy Details
Novartis Investigative Site Bergamo Lombardy 24127 Italy Details
Novartis Investigative Site Milan Lombardy 20133 Italy Details
Novartis Investigative Site Milan Lombardy 20141 Italy Details
Novartis Investigative Site Candiolo Piedmont 10060 Italy Details
Novartis Investigative Site Pisa Tuscany 56126 Italy Details
Novartis Investigative Site Padova Veneto 35128 Italy Details
Novartis Investigative Site Shizuoka 411-8777 Japan Details
Novartis Investigative Site Tokyo 104-0045 Japan Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Leeuwarden 8934 AD Netherlands Details
Novartis Investigative Site Maastricht 6229 HX Netherlands Details
Novartis Investigative Site Nijmegen 6525 GA Netherlands Details
Novartis Investigative Site Rotterdam 3015 GD Netherlands Details
Novartis Investigative Site Auckland 0622 New Zealand Details
Novartis Investigative Site Ålesund 6026 Norway Details
Novartis Investigative Site Oslo 0310 Norway Details
Novartis Investigative Site Gdansk 80-215 Poland Details
Novartis Investigative Site Konin 62-500 Poland Details
Novartis Investigative Site Poznan 60-693 Poland Details
Novartis Investigative Site Warsaw 02-781 Poland Details
Novartis Investigative Site Chelyabinsk 454087 Russia Details
Novartis Investigative Site Moscow 115478 Russia Details
Novartis Investigative Site Moscow 143423 Russia Details
Novartis Investigative Site Ryazan 390011 Russia Details
Novartis Investigative Site Saint Petersburg 191014 Russia Details
Novartis Investigative Site Saint Petersburg 197758 Russia Details
Novartis Investigative Site Saint Petersburg 198255 Russia Details
Novartis Investigative Site Volgograd 400138 Russia Details
Novartis Investigative Site Badalona 08916 Spain Details
Novartis Investigative Site Barcelona 08035 Spain Details
Novartis Investigative Site Barcelona 08036 Spain Details
Novartis Investigative Site Donostia / San Sebastian 20014 Spain Details
Novartis Investigative Site Las Palmas de Gran Canaria 35016 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Palma de Mallorca 07198 Spain Details
Novartis Investigative Site Pamplona 31008 Spain Details
Novartis Investigative Site Santander 39008 Spain Details
Novartis Investigative Site Valencia 46014 Spain Details
Novartis Investigative Site Gothenburg SE-413 45 Sweden Details
Novartis Investigative Site Lund SE-221 85 Sweden Details
Novartis Investigative Site Stockholm SE-171 76 Sweden Details
Novartis Investigative Site Uppsala SE-751 85 Sweden Details
Novartis Investigative Site Basel 4031 Switzerland Details
Novartis Investigative Site Chur 7000 Switzerland Details
Novartis Investigative Site Zurich 8091 Switzerland Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taoyuan 33305 Taiwan Details
Novartis Investigative Site Northwood Middlesex HA6 2RN United Kingdom Details
Novartis Investigative Site Exeter EX2 5DW United Kingdom Details
Novartis Investigative Site Glasgow G12 0YN United Kingdom Details
Novartis Investigative Site Guildford GU2 7XX United Kingdom Details
Novartis Investigative Site Leeds LS9 7TF United Kingdom Details
Novartis Investigative Site London NW3 2QG United Kingdom Details
Novartis Investigative Site London SW3 6JJ United Kingdom Details
Novartis Investigative Site London W1G 6AD United Kingdom Details
Novartis Investigative Site Manchester M20 4BX United Kingdom Details
Novartis Investigative Site Newcastle upon Tyne NE7 7DN United Kingdom Details
Novartis Investigative Site Norwich NR4 7UY United Kingdom Details
Novartis Investigative Site Preston PR2 9HT United Kingdom Details
Novartis Investigative Site Southampton SO16 6YD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field